Ripasudil is a Rho kinase inhibitor indicated for the treatment of ocular hypertension and open-angle glaucoma by facilitating the relaxation of the trabecular meshwork. This category provides essential… Read more











Ripasudil is a Rho kinase inhibitor indicated for the treatment of ocular hypertension and open-angle glaucoma by facilitating the relaxation of the trabecular meshwork. This category provides essential analytical materials for pharmaceutical research and development, including the active pharmaceutical ingredient, related synthetic intermediates, and potential degradation products. Laboratory professionals utilize these high-quality reference standards for rigorous impurity profiling, method validation, and rigorous quality control testing to ensure drug safety and efficacy. By incorporating stable isotope labelled compounds and identified impurities, these products support precise metabolite identification and accurate quantification in complex matrices using advanced techniques such as mass spectrometry and NMR analysis. These chemical standards are vital for investigators and quality assurance teams seeking to maintain compliance throughout the manufacturing and regulatory submission processes for ophthalmic therapeutic formulations.